U.S. MARKETS FOR CARDIOVASCULAR DISEASE DIAGNOSTIC PRODUCTS

382 Pages | 102 Exhibits | 2004 Analysis | Forecasts Through 2007 Product Family: Market Reports




OVERVIEW:
More adults in the U.S. die from cardiovascular diseases/disorders than from any other cause. Nationwide, approximately 64.4 million people have at least one cardiovascular condition; these diseases/disorders kill nearly 2,600 people in the U.S. each day, and result in direct and indirect costs that exceed $368.0 billion annually.

In 2003, more than 154.7 million electrocardiography, endovascular, noninvasive diagnostic imaging, and near patient in vitro testing procedures were performed in the U.S. to diagnose cardiovascular diseases/disorders. These procedures generated approximately $3.6 billion in corresponding product sales, with noninvasive diagnostic imaging systems sales accounting for 45.8% of the total, imaging contrast agents and biopharmaceuticals sales for 21.9%, transcatheter diagnostic systems sales for 17.4%, near patient in vitro testing products sales for 7.9%, and electrocardiography systems sales for 7.0%. Growing at a compound annual rate of 8.0%, sales of these products are expected to reach an estimated $4.8 billion in the year 2007.

This dynamic report from Medtech Insight includes analyses of products, technologies, current and forecast markets, competitors, and opportunities in the U.S. market for cardiovascular disease/disorder diagnostic products.

Covered topics in this report include angiography devices; cardiac marker, cholesterol, and coagulation testing products; cardiovascular disease/disorder incidence, prevalence, and mortality statistics; computed tomography systems; conventional and advanced electrophysiology catheters; conventional X-ray-based imaging systems; diagnostic ultrasound imaging systems; electrocardiography systems; functional angiometry wires; imaging contrast agents/radiopharmaceuticals; intravascular ultrasound systems; magnetic resonance imaging systems; and nuclear medicine imaging systems.

TABLE OF CONTENTS:

EXECUTIVE SUMMARY

i.   Statistical Overview of Cardiovascular Diseases/Disorders

ii.   Cardiovascular Disease/Disorder-Related Diagnostic Procedures and Tests

iii. Cardiovascular Disease/Disorder-Related Diagnostic Products Markets

a. Electrocardiography Systems

b. Diagnostic Imaging Systems

i.   Conventional X-Ray-Based Imaging Systems

ii.   Computed Tomography Systems

iii.  Magnetic Resonance Imaging Systems

iv.  Nuclear Medicine Imaging Systems

v.  Ultrasound Imaging Systems

c. Imaging Contrast Agents and Radiopharmaceuticals

i.   X-Ray/Computed Tomography Contrast Media

ii.   Nuclear Medicine Radiopharmaceuticals

iii.  Ultrasound Contrast Agents

d. Cardiovascular Disease/Disorder-Related Transcatheter Diagnostic Systems

i.   Angiography Devices

ii.   Intravascular Ultrasound Systems

iii.  Functional Angiometry Products

iv.  Diagnostic Electrophysiology Catheters

e. Near Patient, Cardiovascular Disease/Disorder-Related In Vitro Diagnostic Testing Products

i.   Cardiac Marker Systems

ii.   Cholesterol/Lipid Testing Systems

iii.  Coagulation Testing Systems

 

1.   OVERVIEW OF SELECTED CARDIOVASCULAR DISEASES/DISORDERS

1.1 Vascular Diseases/Disorders

1.1.1 Atherosclerosis

1.1.2 Coronary Heart Disease

1.1.2.1 Angina Pectoris

1.1.2.2 Myocardial Infarction

1.1.3 Stroke

1.1.3.1 Hemorrhagic Stroke

1.1.3.2 Ischemic Stroke

1.1.4 Aortic Aneurysm

1.1.5 Venous Thromboembolism

1.1.5.1 Deep-Vein Thrombosis

1.1.5.2 Pulmonary Embolism

1.2 Cardiac Arrhythmias

1.2.1 Sinus Bradycardia

1.2.2 Sick Sinus Syndrome

1.2.3 Heart Block

1.2.3.1 Atrioventricular Block

1.2.3.2 Infranodal Atrioventricular Block

1.2.3.3 Intraventricular Block

1.2.3.4 Sinoatrial Block

1.2.4 Supraventricular Tachycardia

1.2.4.1 Atrial Fibrillation

1.2.4.2 Atrial Flutter

1.2.5 Ventricular Tachycardia

1.2.6 Ventricular Fibrillation

1.2.7 Sudden Cardiac Death

1.3 Myocardial Diseases/Disorders

1.3.1 Congestive Heart Failure

1.3.2 Heart Valve Disorders

1.3.3 Congenital Cardiovascular Defects

1.3.4 Rheumatic Fever/Rheumatic Heart Disease

 

2.   CARDIOVASCULAR DISEASE/DISORDER-RELATED DIAGNOSTIC PROCEDURES AND TESTS

2.1 Electrocardiography-Based Diagnostic Procedures

2.1.1 Resting Electrocardiography

2.1.2 Holter Monitoring

2.1.3 Trans-Telephonic Event Recording

2.1.4 Signal-Averaged Electrocardiography

2.1.5 Exercise Stress Testing

2.2 Noninvasive Imaging in Cardiovascular Diagnostics

2.2.1 Conventional X-Ray-Based Imaging

2.2.1.1 Conventional X-Ray-Based Imaging, Cardiovascular Disease/Disorder-Related Applications

2.2.1.2 Conventional X-Ray-Based Imaging, Procedure Volumes

2.2.2 Computed Tomography

2.2.2.1 Spiral Computed Tomography

2.2.2.2 Electron Beam Computed Tomography

2.2.2.3 Multislice Computed Tomography

2.2.2.4 Computed Tomography Angiography

2.2.2.5 Perfusion Computed Tomography

2.2.2.6 Computed Tomography, Cardiovascular Disease/Disorder-Related Applications

2.2.2.7 Computed Tomography, Procedure Volumes

2.2.3 Magnetic Resonance Imaging

2.2.3.1 Magnetic Resonance Angiography

2.2.3.1.1 Time-of-Flight Magnetic Resonance Angiography

2.2.3.1.2 Phase-Contrast Magnetic Resonance Angiography

2.2.3.1.3 Contrast-Enhanced Magnetic Resonance Angiography

2.2.3.2 Functional Magnetic Resonance Imaging

2.2.3.3 Proton Magnetic Resonance Spectroscopy

2.2.3.4 Interventional Magnetic Resonance

2.2.3.5 Magnetic Resonance Imaging Contrast Media

2.2.3.6 Magnetic Resonance Imaging, Cardiovascular Disease/Disorder-Related Applications

2.2.3.7 Magnetic Resonance Imaging, Procedure Volumes

2.2.4 Nuclear Medicine Imaging

2.2.4.1 Gamma Camera Imaging

2.2.4.2 Positron Emission Tomography Imaging

2.2.4.3 Radioimmunoscintigraphy

2.2.4.4 Fusion Positron Emission Tomography/Computed Tomography Imaging Systems

2.2.4.5 Nuclear Medicine Imaging, Cardiovascular Disease/Disorder-Related Applications

2.2.4.6 Nuclear Medicine Imaging, Procedure Volumes

2.2.5 Diagnostic Ultrasound Imaging

2.2.5.1 Echocardiography

2.2.5.2 Tissue Harmonic Imaging

2.2.5.3 Doppler Imaging

2.2.5.4 Duplex Ultrasonography

2.2.5.5 Three-Dimensional Ultrasound

2.2.5.6 Contrast-Enhanced Ultrasound

2.2.5.7 Diagnostic Ultrasound Imaging, Cardiovascular Disease/Disorder-Related Applications

2.2.5.8 Diagnostic Ultrasound Imaging, Procedure Volumes

2.3 Invasive Imaging Techniques

2.3.1 Angiography

2.3.1.1 Coronary Angiography

2.3.1.2 Peripheral Angiography

2.3.1.2.1 Pulmonary Angiography

2.3.1.2.2 Peripheral Venous Angiography

2.3.1.2.2.1 Deep-Vein Thrombosis

2.3.1.2.2.2 Portal/Splenic Vein Disorders

2.3.1.2.2.3 Visceral Vein Disorders

2.3.1.2.3 Peripheral Arterial Angiography

2.3.1.2.3.1 Lower Extremity Peripheral Vascular Disorders

2.3.1.2.3.2 Acute Mesenteric Ischemia

2.3.1.2.3.3 Chronic Mesenteric Ischemia

2.3.1.2.3.4 Acute Gastrointestinal Bleeding

2.3.1.2.3.5 Abdominal Malignancies

2.3.1.3 Cerebral Angiography

2.3.1.3.1 Cerebral Angiography, Stroke-Related Applications

2.3.1.4 Angiography, Procedure Volumes

2.3.2 Intravascular Ultrasound

2.3.2.1 Intravascular Ultrasound, Procedure Volumes

2.3.3 Functional Angiometry

2.3.3.1 Functional Angiometry, Procedure Volumes

2.3.4 Electrophysiology Studies

2.3.4.1 Electrophysiology Studies, Procedure Volumes

2.4 Near Patient In Vitro Cardiovascular Disease/Disorder-Related Diagnostic Testing

2.4.1 Cardiac Marker Testing

2.4.1.1 Types of Cardiac Marker Tests

2.4.1.1.1 Creatine Kinase-MB

2.4.1.1.2 Myoglobin

2.4.1.1.3 Troponin-I and Troponin-T

2.4.1.1.4 B-Type Natriuretic Peptide

2.4.1.2 Near Patient Rapid Cardiac Marker Analyses, Test Volumes

2.4.2 Cholesterol/Lipid Testing

2.4.2.1 Near Patient Rapid Cholesterol/Lipid Analyses, Test Volumes

2.4.3 Coagulation Testing

2.4.3.1 Types of Coagulation Tests

2.4.3.1.1 Activated Clotting Time

2.4.3.1.2 Activated Partial Thromboplastin Time

2.4.3.1.3 Bleeding Time

2.4.3.1.4 Prothrombin Time

2.4.3.1.5 Thrombin Clotting Time

2.4.3.1.6 Platelet Count/Function Determination

2.4.3.2 Near Patient Rapid Coagulation Analyses, Test Volumes

 

3.   CARDIOVASCULAR DISEASE/DISORDER-RELATED DIAGNOSTIC PRODUCTS MARKETS

3.1 Electrocardiography Systems

3.1.1 Products

3.1.2 Market Forecast

3.1.3 Competitive Analysis

3.2 Diagnostic Imaging Systems

3.2.1 Conventional X-Ray-Based Imaging Systems

3.2.1.1 Products

3.2.1.2 Market Forecast

3.2.1.3 Competitive Analysis

3.2.2 Computed Tomography Systems

3.2.2.1 Products

3.2.2.2 Market Forecast

3.2.2.3 Competitive Analysis

3.2.3 Magnetic Resonance Imaging Systems

3.2.3.1 Products

3.2.3.2 Market Forecast

3.2.3.3 Competitive Analysis

3.2.4 Nuclear Medicine Imaging Systems

3.2.4.1 Products

3.2.4.2 Market Forecast

3.2.4.3 Competitive Analysis

3.2.5 Ultrasound Imaging Systems

3.2.5.1 Products

3.2.5.2 Market Forecast

3.2.5.3 Competitive Analysis

3.3 Imaging Contrast Agents and Radiopharmaceuticals

3.3.1 X-Ray/Computed Tomography Contrast Media

3.3.1.1 Products

3.3.1.2 Market Forecast

3.3.1.3 Competitive Analysis

3.3.2 Nuclear Medicine Radiopharmaceuticals

3.3.2.1 Products

3.3.2.2 Market Forecast

3.3.2.3 Competitive Analysis

3.3.3 Ultrasound Contrast Agents

3.3.3.1 Products

3.3.3.2 Market Forecast

3.3.3.3 Competitive Analysis

3.4 Cardiovascular Disease/Disorder-Related Transcatheter Diagnostic Systems

3.4.1 Angiography Products

3.4.1.1 Angiography Catheters

3.4.1.2 Diagnostic Guidewires

3.4.1.3 Diagnostic Sheaths

3.4.1.4 Angiography Accessories

3.4.1.5 Venography Devices

3.4.1.6 Products

3.4.1.7 Market Forecast

3.4.1.8 Competitive Analysis

3.4.2 Intravascular Ultrasound Systems

3.4.2.1 Products

3.4.2.2 Market Forecast

3.4.2.3 Competitive Analysis

3.4.3 Functional Angiometry Products

3.4.3.1 Market Analysis

3.4.4 Diagnostic Electrophysiology Catheters

3.4.4.1 Products

3.4.4.2 Market Forecast

3.4.4.3 Competitive Analysis

3.5 Near Patient, Cardiovascular Disease/Disorder-Related In Vitro Diagnostic Testing Products

3.5.1 Cardiac Marker Systems

3.5.1.1 Products

3.5.1.2 Market Forecast

3.5.1.3 Competitive Analysis

3.5.2 Cholesterol/Lipid Testing Systems

3.5.2.1 Products

3.5.2.2 Market Forecast

3.5.2.3 Competitive Analysis

3.5.3 Coagulation Testing Systems

3.5.3.1 Products

3.5.3.2 Market Forecast

3.5.3.3 Competitive Analysis

 

4. COMPANY PROFILES

4.1   C.R. Bard, Inc.

4.2   Biosite, Inc.

4.3   Boston Scientific Corporation

4.4   Bracco Group

4.5   Bristol-Myers Squibb Company

4.6   Cholestech Corporation

4.7   Cook Group

4.8   GE Healthcare, Inc./General Electric Company

4.9   International Technidyne Corporation/Thoratec Corporation

4.10 Johnson & Johnson

4.11 Mallinckrodt Imaging/Tyco International LTD

4.12 Medtronic, Inc.

4.13 Nuclear Pharmacy Services/Cardinal Health, Inc.

4.14 Philips Medical Systems/Royal Philips Electronics NV

4.15 Roche Diagnostics/F. Hoffmann-La Roche LTD

4.16 Siemens Medical Solutions/Siemens AG

4.17 Volcano Therapeutics, Inc.

4.18 Welch Allyn, Inc.

 

APPENDIX:  COMPANY LISTING

 

LIST OF EXHIBITS

 

Exhibit ES-1:    Incidence and Prevalence Statistics for Selected Cardiovascular Diseases/Disorders, 2001 and 2007

Exhibit ES-2:    2001, Total Mention Mortality Figures for Selected Cardiovascular Diseases/Disorders

Exhibit ES-3:    Cardiovascular Disease/Disorder-Related Diagnostic Evaluations, Procedure/Test Volumes Forecast, 2002-2007

Exhibit ES-4:    Cardiovascular Disease/Disorder-Related Diagnostic Products, Market Forecast, 2002-2007

Exhibit ES-5:    Electrocardiography Products, Market Forecast, 2002-2007

Exhibit ES-6:    Diagnostic Imaging Systems, Market Forecast, 2002-2007

Exhibit ES-7:    Conventional X-Ray-Based Imaging Systems, Market Forecast, 2002-2007

Exhibit ES-8:    Computer Tomography Systems, Market Forecast, 2002-2007

Exhibit ES-9:    Magnetic Resonance Imaging Systems, Market Forecast, 2002-2007

Exhibit ES-10:   Nuclear Medicine Imaging Systems, Market Forecast, 2002-2007

Exhibit ES-11:   Diagnostic Ultrasound Systems, Market Forecast, 2002-2007

Exhibit ES-12:   Cardiovascular Disease/Disorder-Related Contrast Agent and Radiopharmaceutical Products, Market Forecast, 2002-2007

Exhibit ES-13:   Cardiovascular Disease/Disorder-Related X-Ray/Computed Tomography Imaging Contrast Agents, Market Forecast, 2002-2007

Exhibit ES-14:   Cardiovascular Disease/Disorder-Related Nuclear Medicine Radiopharmaceutical Products, Market Forecast, 2002-2007

Exhibit ES-15:   Cardiovascular Disease/Disorder-Related Diagnostic Ultrasound Contrast Media, Market Forecast, 2002-2007

Exhibit ES-16:   Cardiovascular Disease/Disorder-Related Transcatheter Diagnostic Products, Market Forecast, 2002-2007

Exhibit ES-17:   Angiography Devices, Market Forecast, 2002-2007

Exhibit ES-18:   Diagnostic Intravascular Ultrasound Catheters, Market Forecast, 2002-2007

Exhibit ES-19:   Functional Angiometry Wires, Market Forecast, 2002-2007

Exhibit ES-20:   Diagnostic Electrophysiology Catheters, Market Forecast, 2002-2007

Exhibit ES-21:   Near Patient, Cardiovascular Disease/Disorder-Related In Vitro Diagnostic Testing Systems, Market Forecast, 2002-2007

Exhibit ES-22:   Near Patient Cardiac Marker Testing Systems, Market Forecast, 2002-2007

 

Exhibit ES-23:   Near Patient Cholesterol/Lipid Testing Systems, Market Forecast, 2002-2007

Exhibit ES-24:   Near Patient Coagulation Testing Systems, Market Forecast, 2002-2007

 

Exhibit 1-1:      Standard Angina Pectoris Classification

Exhibit 1-2:      Clinical Symptoms and Risk Factors Associated With Hemorrhagic Stroke

Exhibit 1-3:      Clinical Symptoms and Risk Factors Associated With Ischemic Stroke

Exhibit 1-4:      Incidence and Prevalence Statistics for Selected Vascular Diseases/Disorders, 2001 and 2007

Exhibit 1-5:      2001, Total Mention Mortality Figures for Selected Vascular Diseases/Disorders

Exhibit 1-6:      Incidence and Prevalence Statistics for Selected Cardiac Arrhythmias, 2001 and 2007

Exhibit 1-7:      2001, Total Mention Mortality Figures for Selected Cardiac Arrhythmias

Exhibit 1-8:      Incidence and Prevalence Statistics for Selected Myocardial Diseases/Disorders, 2001 and 2007

Exhibit 1-9:      2001, Total Mention Mortality Figures for Selected Myocardial Diseases/Disorders

 

Exhibit 2-1:      Cardiovascular Disease/Disorder-Related Diagnostic Evaluations, Procedure/Test Volumes Forecast, 2002-2007

Exhibit 2-2:      Diagnostic Electrocardiography, Procedure Volumes Forecast, 2002-2007

Exhibit 2-3:      Cardiovascular Disease/Disorder-Related Conventional X-Ray-Based Imaging, Procedure Volumes Forecast, 2002-2007

Exhibit 2-4:      Cardiovascular Disease/Disorder-Related Computed Tomography, Procedure Volumes Forecast, 2002-2007

Exhibit 2-5:      Cardiovascular Disease/Disorder-Related Magnetic Resonance Imaging, Procedure Volumes Forecast, 2002-2007

Exhibit 2-6:      Cardiovascular Disease/Disorder-Related Nuclear Medicine Imaging, Procedure Volumes Forecast, 2002-2007

Exhibit 2-7:      Cardiovascular Disease/Disorder-Related Diagnostic Ultrasound, Procedure Volumes Forecast, 2002-2007

Exhibit 2-8:      Angiography, Procedure Volumes Forecast, 2002-2007

Exhibit 2-9:      Intravascular Ultrasound, Procedure Volumes Forecast, 2002-2007

Exhibit 2-10:     Functional Angiometry, Procedure Volumes Forecast, 2002-2007

Exhibit 2-11:     Electrophysiology Studies, Procedure Volumes Forecast, 2002-2007

Exhibit 2-12:     Near Patient Rapid Cardiac Marker, Cholesterol/Lipid, and Coagulation Analyses, Test Volumes Forecast, 2002-2007

Exhibit 2-13:     Cardiac Marker Analyses, Test Volumes Forecast, 2002-2007

Exhibit 2-14:     Cholesterol/Lipid Analyses, Test Volumes Forecast, 2002-2007

Exhibit 2-15:     Coagulation Analyses, Test Volumes Forecast, 2002-2007

 

Exhibit 3-1:      Cardiovascular Disease/Disorder-Related Diagnostic Examinations, by Modality, Procedure/Test Volumes Forecast, 2002-2007

Exhibit 3-2:      Cardiovascular Disease/Disorder-Related Diagnostic Products, Market Forecast, 2002-2007

Exhibit 3-3:      2004, Selected Electrocardiography Systems

Exhibit 3-4:      Electrocardiography Products, Market Forecast, 2002-2007

Exhibit 3-5:      2003, Electrocardiography Products Market, Share by Supplier

Exhibit 3-6:      Diagnostic Imaging Systems, Market Forecast, 2002-2007

Exhibit 3-7:      2004, Selected X-Ray-Based Cardiovascular Imaging Systems

Exhibit 3-8:      Conventional X-Ray-Based Imaging Systems, Market Forecast, 2002-2007

Exhibit 3-9:      2003, Conventional X-Ray-Based Imaging Systems Market, Share by Supplier

Exhibit 3-10:     2004, Selected Computed Tomography Systems

Exhibit 3-11:     Computer Tomography Systems, Market Forecast, 2002-2007

Exhibit 3-12:     2003, Computed Tomography Systems Market, Share by Supplier

Exhibit 3-13:     2004, Selected Magnetic Resonance Imaging Systems

Exhibit 3-14:     Magnetic Resonance Imaging Systems, Market Forecast, 2002-2007

Exhibit 3-15:     2003, Magnetic Resonance Imaging Systems Market, Share by Supplier

Exhibit 3-16:     2004, Selected Nuclear Medicine Imaging Systems

Exhibit 3-17:     Nuclear Medicine Imaging Systems, Market Forecast, 2002-2007

Exhibit 3-18:     2003, Nuclear Medicine Imaging Systems Market, Share by Supplier

Exhibit 3-19:     2004, Selected Diagnostic Ultrasound Systems

Exhibit 3-20:     Diagnostic Ultrasound Systems, Market Forecast, 2002-2007

Exhibit 3-21:     2003, Diagnostic Ultrasound Systems Market, Share by Supplier

Exhibit 3-22:     Contrast-Enhanced Cardiovascular Diagnostic Imaging, Procedure Volumes Forecast, 2002-2007

Exhibit 3-23:     Cardiovascular Disease/Disorder-Related Contrast Agent and Radiopharmaceutical Products, Market Forecast, 2002-2007

Exhibit 3-24:     Cardiovascular Disease/Disorder-Related X-Ray/Computed Tomography Imaging Contrast Agents, Market Forecast, 2002-2007

Exhibit 3-25:     2003, Cardiovascular Disease/Disorder-Related X-Ray/Computed Tomography Contrast Agents Market, Share by Supplier

Exhibit 3-26:     Cardiovascular Disease/Disorder-Related Nuclear Medicine Radiopharmaceutical Products, Market Forecast, 2002-2007

Exhibit 3-27:     2003, Cardiovascular Disease/Disorder-Related Nuclear Medicine Radiopharmaceutical Products Market, Share by Supplier

Exhibit 3-28:     Cardiovascular Disease/Disorder-Related Diagnostic Ultrasound Contrast Media, Market Forecast, 2002-2007

Exhibit 3-29:     2003, Cardiovascular Disease/Disorder-Related Diagnostic Ultrasound Contrast Media Market, Share by Supplier

Exhibit 3-30:     Cardiovascular Disease/Disorder-Related Transcatheter Diagnostic Examinations, Procedure Volumes Forecast, 2002-2007

Exhibit 3-31:     Cardiovascular Disease/Disorder-Related Transcatheter Diagnostic Products, Market Forecast, 2002-2007

Exhibit 3-32:     Transcatheter Device Usage per Cerebral, Coronary, and Peripheral Angiography Procedure

Exhibit 3-33:     2004, Selected Coronary Angiography Catheters

Exhibit 3-34:     2004, Selected Cerebral/Peripheral Angiography Catheters

Exhibit 3-35:     Angiography Devices, Market Forecast, 2002-2007

Exhibit 3-36:     2003, Coronary Angiography Devices Market, Share by Supplier

Exhibit 3-37:     2003, Cerebral/Peripheral Angiography Devices Market, Share by Supplier

Exhibit 3-38:     2004, Selected Intravascular Ultrasound Catheters

Exhibit 3-39:     Diagnostic Intravascular Ultrasound Catheters, Market Forecast, 2002-2007

Exhibit 3-40:     2003, Diagnostic Intravascular Ultrasound Catheters Market, Share by Supplier

Exhibit 3-41:     Functional Angiometry Wires, Market Forecast, 2002-2007

Exhibit 3-42:     2004, Selected Diagnostic Electrophysiology Catheters

Exhibit 3-43:     Diagnostic Electrophysiology Catheters, Market Forecast, 2002-2007

Exhibit 3-44:     2003, Conventional Diagnostic Electrophysiology Catheters Market, Share by Supplier

Exhibit 3-45:     2003, Advanced Diagnostic/Mapping Electrophysiology Catheters Market, Share by Supplier

Exhibit 3-46:     Near Patient, Cardiovascular Disease/Disorder-Related In Vitro Diagnostic Testing Systems, Market Forecast, 2002-2007

Exhibit 3-47:     2004, Selected Near Patient Cardiac Marker Testing Systems

Exhibit 3-48:     Near Patient Cardiac Marker Testing Systems, Market Forecast, 2002-2007

Exhibit 3-49:     2003, Near Patient Cardiac Marker Testing Systems Market, Share by Supplier

Exhibit 3-50:     2004, Selected Near Patient Cholesterol/Lipid Testing Systems

Exhibit 3-51:     Near Patient Cholesterol/Lipid Testing Systems, Market Forecast, 2002-2007

Exhibit 3-52:     2003, Near Patient Cholesterol/Lipid Testing Systems Market, Share by Supplier

Exhibit 3-53:     Near Patient Coagulation Testing Systems, Market Forecast, 2002-2007

Exhibit 3-54:     2003, Near Patient Coagulation Testing Systems Market, Share by Supplier



COMPANIES COVERED:

  1. C.R. Bard, Inc.
  2. Biosite, Inc.
  3. Boston Scientific Corporation
  4. Bracco Group
  5. Bristol-Myers Squibb Company
  6. Cholestech Corporation
  7. Cook Group
  8. GE Healthcare, Inc./General Electric Company
  9. International Technidyne Corporation/Thoratec Corporation
  10. Johnson & Johnson
  11. Mallinckrodt Imaging/Tyco International LTD
  12. Medtronic, Inc.
  13. Nuclear Pharmacy Services/Cardinal Health, Inc.
  14. Philips Medical Systems/Royal Philips Electronics NV
  15. Roche Diagnostics/F. Hoffmann-La Roche LTD
  16. Siemens Medical Solutions/Siemens AG
  17. Volcano Therapeutics, Inc.
  18. Welch Allyn, Inc.
Contact Us

Need help finding medtech research? Let us help you!